# An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

> **NCT01269021** · NA · COMPLETED · sponsor: **Zhi-Hong Liu, M.D.** · enrollment: 176 (actual)

## Conditions studied

- IgA Nephropathy (IgAN)

## Interventions

- **DRUG:** mycophenolate mofetil plus lower dose of Prednisone
- **DRUG:** Prednisone in full dose

## Key facts

- **NCT ID:** NCT01269021
- **Lead sponsor:** Zhi-Hong Liu, M.D.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-10
- **Final completion:** 2014-04
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269021, "An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01269021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*